Related Experiment Video
Updated: Jan 29, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma
KeShan Wang1,2, TianBo Xu1,2, HaiLong Ruan1,2
1Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Abstract:
Notwithstanding the researches on biomarkers and targeted therapies in renal cell carcinomas (RCC) have made progress in the last decades, the application of the biomarkers and targeted therapy agents for RCC in clinic are restricted because of their limitation or side effects. Liver X receptors (LXRs) and the NLRP3 inflammasome have been the research hotspots in recent years. In our study, we integrated bioinformatics analysis, molecular biology experiments and biological function experiments to study the roles of LXRα and the NLRP3 inflammasome in RCC. The study demonstrated that the elevated LXRα expression is correlated with a poor prognosis in RCC. Furthermore, our study revealed the expression levels and roles of the NLRP3 inflammasome in RCC for the first time. This research demonstrated that LXRα could promote the metastasis of RCC cells by suppressing the expression of the NLRP3 inflammasome. In Brief, LXRα had the possibility to be a novel diagnostic and prognostic biomarker and therapeutic target in renal cell cancer and LXRα could regulate the metastasis of renal cell cancer via NLRP3 inflammamsome.
Insights
Liver X receptor alpha (LXRα) promotes renal cell carcinoma (RCC) metastasis by suppressing the NLRP3 inflammasome. LXRα may serve as a novel biomarker and therapeutic target for RCC.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Current renal cell carcinoma (RCC) treatments face limitations due to side effects and biomarker applicability.
- Liver X receptors (LXRs) and the NLRP3 inflammasome are emerging research areas with potential clinical relevance.
Purpose of the Study:
- To investigate the roles of Liver X receptor alpha (LXRα) and the NLRP3 inflammasome in renal cell carcinoma (RCC).
- To explore the potential of LXRα as a diagnostic and prognostic biomarker and therapeutic target in RCC.
Main Methods:
- Bioinformatics analysis
- Molecular biology experiments
- Biological function experiments
Main Results:
- Elevated LXRα expression correlates with poor prognosis in RCC patients.
- The expression levels and functions of the NLRP3 inflammasome in RCC were elucidated for the first time.
- LXRα was found to promote RCC cell metastasis by suppressing NLRP3 inflammasome expression.
Conclusions:
- LXRα shows potential as a novel diagnostic and prognostic biomarker for RCC.
- Targeting LXRα may offer a new therapeutic strategy for managing RCC metastasis.
- LXRα regulates RCC metastasis through its interaction with the NLRP3 inflammasome.
More Related Videos
Related Concept Videos
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
The Eukaryotic Promoter Region
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Regulation of Hematopoietic Stem Cells
Hormonal Regulation
Master Transcription Regulators

